Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Interest Coverage Ratio: 2022-2023

Historic Interest Coverage Ratio for Candel Therapeutics (CADL) over the last 2 years, with Dec 2023 value amounting to 2.28.

  • Candel Therapeutics' Interest Coverage Ratio rose 116.30% to 2.28 in Q4 2023 from the same period last year, while for Dec 2023 it was 14.79, marking a year-over-year change of. This contributed to the annual value of 15.97 for FY2024, which is 7.93% up from last year.
  • As of Q4 2023, Candel Therapeutics' Interest Coverage Ratio stood at 2.28, which was up 117.25% from -13.25 recorded in Q3 2023.
  • In the past 5 years, Candel Therapeutics' Interest Coverage Ratio registered a high of 2.28 during Q4 2023, and its lowest value of -49.73 during Q2 2022.
  • Moreover, its 2-year median value for Interest Coverage Ratio was -14.87 (2023), whereas its average is -17.50.
  • Data for Candel Therapeutics' Interest Coverage Ratio shows a peak YoY soared of 116.30% (in 2023) over the last 5 years.
  • Quarterly analysis of 2 years shows Candel Therapeutics' Interest Coverage Ratio stood at -14.02 in 2022, then skyrocketed by 116.30% to 2.28 in 2023.
  • Its Interest Coverage Ratio stands at 2.28 for Q4 2023, versus -13.25 for Q3 2023 and -14.87 for Q2 2023.